Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-06-13
2010-12-14
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023100, C536S023500, C536S024100
Reexamination Certificate
active
07851161
ABSTRACT:
The present invention discloses methods of using the methylation status of the COX-2 gene promoter region as a biomarker for a gastric cancer patient to determine a prognosis and a treatment regimen, and to monitor the progress of a treatment regimen.
REFERENCES:
patent: 2004/0170977 (2004-09-01), Laird
patent: 2006/0051768 (2006-03-01), Hoon et al.
patent: 2007/0161029 (2007-07-01), Li et al.
de Maat et al. Journal of Clinical Oncology. 2007. 25: 4887-4894.
Bastian et al. European Urology. Mar. 2007. 51: 665-674.
Nishiyama et al. Cancer Biology and Therapy. 2005. 4: 440-448.
Battagli et al. Cancer Research. Dec. 2003. 63: 8695-8699.
Chow et al. Biomedicine and Pharmacotherapy. 2005. 59: S264-S267.
Ehrlich et al. (Oncogene 2002. 21: 5400-5413.
Nimmrich et al. Breast Cancer Research and Treatment. 2008. 111:429-437.
Watanabe et al. Anticancer Research. 2003. 23(4): 3215-3221.
Buchanan et al, “RN: Connecting COX-2 and Wnt in Cancer,” Cancer Cell, 9:6-8 (2006).
Buskens et al, “Comparison of Cyclooxygenase 2 Expression in Adenocarcinomas of the Gastric Cardia and Distal Oesophagus,” Gut. 52:1678-1683 (2003).
Hartgrink et al, “Neo-Adjuvant Chemotherapy for Operable Gastric Cancer: Long Term Results of the Dutch Randomised FAMTX Trial,” EJSO, 30:643-649 (2004).
Huang et al, “Infrequent COX-2 Expression Due to Promoter Hypermethylation in Gastric Cancers in Dalian, China,” Human Pathology 37:1557-1567 (2006).
Hur et al, “Aberrant Methylation of the Specific CpG Island Portion Regulates Cyclooxygenase-2 Gene Expression in Human Gastric Carcinomas,” Biochemical and Biophysical Research Communications, 310:844-851 (2003).
Kang et al, “Aberrant CpG island Hypermethylation of Chronic Gastritis, in Relation to Aging, Gender, Intestinal Metaplasia, and Chronic Inflammation,” American Journal of Pathology, 163:1551-1556 (2003).
Kang et al, “Profile of Aberrant CpG Island Methylation Along the Multistep Pathway of Gastric Carcinogenesis,” Laboratory Investigation, 83:635-641 (2003).
Leung et al, “Cyclooxygenase-2 Upregulates Vascular Endothelial Growth Factor Expression and Angiogenesis in Human Gastric Carcinoma,” International Journal of Oncology, 23:1317-1322 (2003).
Mrena et al, “Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Cancer and its Expression is Regulated by the Messenger RNA Stability Factor HuR,” Clinical Cancer Research, 11:7362-7368 (2005).
Murata et al, “Cyclooxygenase-2 Overexpression Enhances Lymphatic Invasion and Metastasis in Human Gastric Carcinoma,” American Journal of Gastroenterology, 94:451-455 (1999).
Regalo et al, “C/EBPbeta is Over-Expressed in Gastric Carcinogenesis and is Associated with COX-2 Expression,”. Journal of Pathology, 210:398-404 (2006).
Ristimaki et al, “Expression of Cyclooxygenase-2 in Human Gastric Carcinoma,” Cancer Research, 57:1276-1280 (1997).
Tatsuguchi et al, “Cyclooxygenase-2 Expression Correlates with Angiogenesis and Apoptosis in Gastric Cancer Tissue,” Human Pathology, 35:488-495 (2004).
Toyota et al, “Aberrant Methylation in Gastric Cancer Associated with the CpG Island Methylator Phenotype,” Cancer Research, 59:5438-5442 (1999).
Wang et al, “Mechanism and Clinical Significance of Cyclooxygenase-2 Expression in Gastric Cancer,” World J. Gastroenterol, 11:3240-3244 (2005).
PCT International Search Report, mailing date Sep. 9, 2008.
Ma et al., “Promoter Methylation Regulates Cyclooxygenase Expression in Breast Cancer,” Breast Cancer Res., pp. R316-R321 (2004).
Murata et al., “Promoter Hypermethylation Silences Cyclooxygenase-2(Cox-2)and Regulates Growth of Human Hepatocellular Carcinoma Cells,” Lab Invest., 84, pp. 1050-1059 (2004).
Song et al., “Transcriptional Silencing of Cyclooxygenase-2 by Hyper-Methylation of the 5′ CpG Island in Human Gastric Carcinoma Cells,” Cancer Research, 61, pp. 4628-4635 (2001).
de Maat Michiel
Hoon Dave S. B.
John Wayne Cancer Institute
Myers Carla
Perkins Coie LLP
LandOfFree
Epigenetic silencing of cyclooxygenase-2 affects clinical... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Epigenetic silencing of cyclooxygenase-2 affects clinical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epigenetic silencing of cyclooxygenase-2 affects clinical... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4182570